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Introduction and objective: One of the  consequences of the CKD, is the deterioration of the
functional capacity, being able to manifest from different stages of the disease, until renal
replacement therapy.
The objective of this study was to determine the functionality of patients with CKD
through functional capacity test, valuing the usefulness of the SPPB as  a  screening test
in  parallel.
Materials and methods: It assessed the functional capacity of patients with CKD, using the
test  SPPB, 6MM, TUTG and STS. Also found the muscle strength with manual dynamometry.
Results: Of 121 patients who came to the CKD query, 118 presented a  minimum functionality
to perform tests of functional capacity, a  71.2% of the  patients were  able to perform 4 tests,
a  28.8% only could make the SPPB test.
To  a  71.43% of patients who presented a  low score in SPPB, not  could follow assessed
them with the  rest of the test, while the  92.31% of which had a  high score, continued with
the  rest of the evidence. To differentiate by age ranges, the majority of young patients have
minimal limitations, finding higher rates of disability in older age ranges. A good score in
SPPB meant to present good functional capacity and allowed to continue evaluating the
patient, obtaining better results with the rest of test and more muscle strength. A good
nutritional better status and body composition was a  better functionality.
Conclusion: In the absence of a consensus of what is the  best method of determining the
functional capacity of the kidney patient, and to assess all patients, propose to  use the  test
SPPB as  screening method, and depending on the result used as  the rest of the  test to  more
complete if it is necessary to study.
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¿Es  útil  el SPPB como  método  de screening  de capacidad  funcional  en
pacientes  con  enfermedad  renal  crónica  avanzada?
Palabras clave:
Enfermedad renal crónica
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Capacidad funcional
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Test 6 minutos marcha
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Test  sit to stand 5
Test  sit to stand 10
Test  sit to stand 30
Test  sit to stand 60
Dinamometría
r  e s u m  e n
Introducción y objetivo: Una de  las consecuencias de  la ERC, es el  deterioro de  la capaci-
dad  funcional, pudiéndose manifestar desde distintos estadios de la enfermedad, hasta el
tratamiento renal  sustitutivo.
El  objetivo de este estudio fue  determinar la funcionalidad de los pacientes con ERCA, medi-
ante  test de  capacidad funcional, valorando de forma paralela la utilidad del SPPB como test
de  cribado.
Materiales y métodos: Se evaluó la capacidad funcional de pacientes ERCA, utilizando los
test  SPPB, 6MM, TUTG y  STS. También se  determinó la fuerza muscular con dinamometría
manual.
Resultados: De 121 pacientes que acudieron a  la consulta ERCA, 118 presentaron una mínima
funcionalidad para poder realizar pruebas de capacidad funcional, un 71,2% de  los pacientes
fueron  capaces de  realizar los 4 test, un 28,8% solo pudo realizar el  test SPPB.
A  un 71,43% de pacientes que presentaron una puntuación baja en SPPB, no se les  pudo
seguir evaluando con el resto de test, mientras que el 92,31% de los que presentaron
una puntuación alta, continuaron con el resto de pruebas. Al diferenciar por  rangos de
edad,  la mayoría de los pacientes jóvenes presentaban mínimas limitaciones, encontrando
tasas  más  altas de  discapacidad en rangos de  edad mayores. Una buena puntuación en
SPPB supuso presentar buena capacidad funcional y  permitió seguir evaluando al paciente,
obteniendo mejores resultados con el resto de test y más fuerza muscular. Una buena
composición corporal y mejor estado nutricional supuso una mejor funcionalidad.
Conclusión: A falta de  un consenso de cuál es el mejor método de determinar la capacidad
funcional del paciente renal, y  para poder evaluar a  todos los pacientes, proponemos utilizar
el  test SPPB como método de screening, y  en función del resultado utilizar el  resto de los
test  para realizar estudio más completo si es necesario.
©  2019 Sociedad Espan˜ola de  Nefrologı´a. Publicado por  Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Introduction
Chronic kidney disease (CKD) affects approximately 7–12% of
the population, with rates varying by geographical area, and
is one of the leading causes of death together with type 2
diabetes and cardiovascular disease.1
The organisation Kidney Disease Improving Global Out-
comes defines CKD as  sustained kidney injury for at least three
months, diagnosed:
1. Directly due to histological alterations in renal biopsy, or
indirectly due to the presence of albuminuria or urinary
sediment abnormalities or through imaging techniques.
2.  By calculation of glomerular filtration rate (being consid-
ered as below 60 ml/min/1.73 m2).  There are a  number of
formulas, but the CKD-EPI is  the one that best differentiate
the patient into the different stages and is therefore the
one that should be used.1
Progression of CKD is  associated with a  deterioration in
functional capacity, mainly due to the loss and/or atrophy
of muscle mass, myopathy, inactivity and malnutrition lead-
ing to a reduction in physical capacity, which may  become
evident in more  advanced stages of CKD before renal replace-
ment therapy is required.2–4
Increased life expectancy means that patients became
older. Thus, it is necessary to assess their physical capacity,
and there has to be included the disease-related deterioration
in addition to  the decrease in  activity in older patients. More-
over, a  decrease in functional capacity is a prognostic factor of
death, a  high rate of hospital admissions and poor quality of
life.5–9
There are different tests to  evaluate functional capacity,
and it is possible to choose which test fit the  population to
be assessed. To perform a  full study, it may  even be  neces-
sary to use a combination of several tests. With the increase
in age and their associated comorbidities, some tests may  not
be valid for all patients. It may be necessary to use tests valid
for geriatric population.10,11
The aim of this study was to determine the functional
capacity of patients with advanced chronic kidney disease
(CKD) using various functional tests and determine the rela-
tionship of functional capacity with body composition, muscle
strength and nutritional status. At the same time it  was
assessed the utility of the Short Physical Performance Bat-
tery (SPPB) as  a screening test, as  this can be used in all
patients.
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Materials  and  methods
Cross-sectional, prospective study, including 118 patients
from the advanced CKD clinic at Hospital Universitario de
la Princesa, in Madrid, that were assessed over 12 months
according to usual practice (from January to  December 2017).
Patients included had a GFR lower than 45 ml/min/1.73 m2
measured by CKD-EPI (CKD stages 3B, 4 and 5) excluding those
patients without a minimal mobility. The following studies
were performed:
1. Biochemical study of classic nutritional parameters and part of
routine clinical practice in the clinic: albumin, prealbumin,
CRP, lymphocytes, transferrin and estimation of glomerular
filtration rate using the CKD-EPI formula.
2. Assessment of body composition using single-frequency
bioimpedance, with the Bioelectrical Impedance Anal-
yser (AKERN BIA-101); the  patient was  laid on a trolley
bed, with all metal objects removed (ring, bracelets,
chains, keys, etc.), one  pair of electrodes was  placed on
the right hand and another on the right foot and they
were then connected. This measurement provides resis-
tance and reactance data, and with the  specific software
for the device model, the  following data were obtained:
phase angle, Na/K and percentages of total body water,
intracellular water, fat mass and muscle mass (%MM).
3. Anthropometric study: the circumferences of the  arm, waist
and hip were measured with a  non-elastic anthropometric
tape measure, and the triceps skinfold (TSF) was mea-
sured with a  Holtain calliper (model HOL-9810ND), the arm
muscle circumference (AMC) calculated with the formula:
AMC  =  arm circumference (cm) − (  × TSF [mm]).
4. Malnutrition status – inflammation: we used the Malnutrition-
Inflammation Score (MIS), which utilize components of the
subjective global assessment in  combination with body
mass index, serum albumin and transferrin. Each of the ten
components of the scale are graduated according to sever-
ity (from normal to very severe), and the sum of the score
of the ten components classifies the patient according to
their degree of malnutrition.12
5. Determination of muscle strength using a Baseline hand
dynamometer (model Baseline 12-0240). Both arms are
measured three times at 90◦,  taking the highest value for
each arm.11,13–15
6. Assessment of functional capacity: we  chose the following
functional capacity tests: Short Physical Performance Bat-
tery (SPPB), 6-Minute Walk  Test (6MWT), Timed Up and Go
(TUG) test and the Sit-to-Stand (STS) test (also perform-
ing  the 4  variants described for  this last test). These tests
were chosen because they are some of the most used in
CKD, easily reproducible, not requiring specific facilities or
materials and because they are validated in CKD.
•  SPPB: this is a short test battery, widely used in  geriatrics,
which assesses the patient from three points of view: it mea-
sures the patient’s balance, assessing whether or  not they
are able to maintain their balance for at least 10  s with their
feet together, in semi-tandem and full tandem: it  assesses
gait speed by measuring the time it  takes to walk 4  m; and it
assesses lower extremity strength and endurance, measur-
ing the time it takes to sit down and stand up  five times
(STS5). Adding the scores from each test, the total score
indicates the patient’s degree of disability; from the  low-
est to the highest score the  patient would be  classified with
severe, moderate, or  mild limitations or  with minimal/no
limitations, i.e. the higher the score, the fewer the  limita-
tions the patient has.8,9,11,16–19 A flowchart of the SPPB is
shown in Fig. 1.
• 6MWT: this test measures endurance. It consists of the
patient walking a  distance of 30–35 m (for example, along
a  corridor) for 6 min; the total distance is  obtained by mul-
tiplying the length of the corridor by the number of times
the patient covers that distance.11,14,16,17
• TUG test: this test assesses the risk of falling. It  consists of
measuring the time taken to  get up from a sitting position,
walk three metres and sit down again. If the time is  less
than 10 s the patient is not at risk of falling.8,11,17,20,21
• STS test and its four variants: this test assesses lower
extremity strength and endurance; STS5 and STS10 consist
of measuring the time it takes to get up  from a chair and sit
back down five or  ten times and the  STS30 and STS60 count
the number of times they can get up and sit back down in
30  and 60 s,  respectively.11,17,22–24
Statistical  analysis
The qualitative data is described using absolute fre-
quencies and percentages and the quantitative data, by
mean ± standard deviation (SD), median and interquartile
range (P25–P75 –  IQR), minimum and maximum.
Quantitative data were analysed using the
Kolmogorov–Smirnov test to assess normal distribution.
The comparison of quantitative data between groups was
performed using the Mann–Whitney U test and the Student’s t
test. Qualitative data were compared using the chi-square test.
The study of the correlations between quantitative variables
was performed using Spearman’s or Pearson’s coefficient of
correlation, according to the distribution of the data.
All statistical tests were considered bilateral and p-values
lower than 0.05 as  significant. The data were analysed with
the statistical program SPSS version 23.0 (IBM Corp., Armonk,
NY, USA).
Results
Of the  total of 121 patients who attended the advanced
CKD clinic over the one-year period, only 118 were taken
into account; three patients (2.48%) were excluded, as they
were not able to perform any of the functional tests pro-
posed; two because they were in a wheelchair, and the
third due to a  recent stroke. Of the 118 patients, 71.2%
(84 patients) were able to perform all four tests (SPPB,
6MWT, TUTG and STS) and 28.8% (34 patients) were only
able to perform the  SPPB. Fig. 2 shows the percentages of
patients who completed the different tests proposed in the
study.
Of the 118 patients, 76 (64.4%) were male and 42 (35.6%)
female. The median age was 74 (62–80), with a  range of 36–94
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2.
3.
Balance tests
Side-by-side stand
feet  together side-by-side for 10 s
<10 s (0 pt)
<10 s (+0 pt)
10 s (+1 pt)
Tandem stan d
feet aligned heel to toe for 10 s
Go to 4-meter
gait speed test
Go to 4-meter
gait speed test
10 s (1 pt)
Semi-tandem stand
heel of one fo ot against side of big toe of the
other fo r 10 s
10 s (+ 2pt)
<4.82 s 
4.82-6.20 s
6.21-8.70 s
>8.7 s
Unable
4 pt
3 pt
2 pt
1 pt
0 pt
3-9.99 s (+1 pt)
<3 s (+0 pt)
Gait speed test
Measures the time required to walk 4 metres
at a normal pace (use best of 2 times)
1 m 2 m 3 m 4 m
Chair stand test
Pre-test
Participants fold their arms across their chest
and try to stand up once from a chair
unable
able
5 repeat s
Measures the time required to perform five rise s
from a chair to an upright position as fast as
possible without the use of the arms
Stop (0 pt)
<11.19 s 4 pt
3 pt
2 pt
1 pt
0 pt
11.20-13.69 s
13.70-16.69 s
>16.7 s
>60 s or unable 
Fig. 1 – Flowchart for the SPPB.19.
Only 28.8%
2.48% none
All 71.2%
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n
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STS
STS 5
STS 10
STS 30
STS 60
Fig. 2 – Percentage of patients who  completed or did not
complete the functional tests.
years, with no significant difference in the mean age of males
and females.
The table below (Table 1)  shows the clinical biochemistry
and body composition data.
With respect to glomerular filtration calculated by the CKD-
EPI equation, 33.9% had a  stage 5 CKD, 58.9% stage 4, and 10.2%
stage 3B.
The score for the nutritional study using a  malnutrition-
inflammation score (MIS) was 5.40 ±  2.82, which corresponds
to  mild-to-moderate malnutrition or risk of malnutrition.
Table 2  shows how most of the patients with a high score in
the SPPB test (minimal limitations and mild limitations) were
able to perform what we  have called a  “full assessment” (con-
sisting of the 6MWT and TUG tests and the 4 STS tests), while
the majority of those who obtained a  lower score were not able
to do the full  assessment.
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Table 1 – Results of biochemical parameters and body composition by  bioimpedance-anthropometry.
x¯ ±  SD Minimum Maximum
Weight (kg)  74.52 ±  15.30 35.40 124.00
Haemoglobin (g/dl) 12.30 ±  1.54 8.50 16.70
Total lymphocytes (thou./mm3) 2173.58 ±  879.44 270 4860.00
Transferrin (mg/dl) 216.84 ±  53.71 69.00 2650.00
Albumin (g/dl) 4.02 ±  0.43 1.90 5.10
Prealbumin (mg/dl) 28.60 ±  6.79 11.71 52.95
CRP (mg/dl) 0.60 ±  0.89 0.00 6.20
Plasma creatinine (mg/dl) 3.21 ±  1.14 1.18 7.44
Proteinuria ((mg/dl) 64.02 ±  88.83 2.00 525.00
CKD-EPI (ml/min/1.73 m2) 19.18 ±  7.41 7.03 40.89
PA 4.20 ±  0.99 2.20 7.20
Na/K 1.34 ±  0.37 0.80 2.50
% BCM 37.70 ±  8.04 20.00 61.70
% Total body water 52.10 ±  6.84 36.70 77.70
% Intracellular water 44.52 ±  7.32 26.20 59.60
% Fat mass 33.75 ±  9.41 8.30 54.10
% Lean mass 65.98 ±  9.15 45.90 88.00
% Muscle mass 32.88 ±  7.94 18.90 69.20
BCMI 6.46 ±  1.92 3.00 16.00
BMI (kg/m2) 27.44 ±  5.15 14  46
AMC (cm) 29.21 ±  4.00 15.87 39.77
Waist circumference (cm) 100.47 ±  13.46 69.00 142.00
Hip circumference (cm) 100.01 ±  8.37 81.00 130.00
Waist-to-hip ratio 0.99 ±  0.10 0.76 1.32
Table 2 – SPPB contingency table vs “full assessment”.
SPPB test interpretation Full assessment p
Yes No
Severe limitations 28.57% 71.43% 0.000
Moderate limitations 39.13% 60.87%
Mild limitations 69.44% 30.56%
Minimal limitations – no limitations 92.31% 7.69%
The analysis separating by age (Table 3), revealed that no
patients under 65  had severe limitations in the SPPB, the
majority having minimal limitations, and similar results were
obtained in the 65–74 age group. The 75–84 age group included
the largest number of patients, and also the largest num-
ber patients classified with mild or moderate limitations.
The group with age over-85 had the highest percentage of
moderate-to-severe limitations.
Table 4 shows the results obtained in the different tests
of functional capacity and muscle strength; the data are
expressed as median and interquartile range (IQR), as well as
maximum and minimum values.
Table 4 – Test results for functional capacity and muscle
strength with dynamometer.
Median (P25–P75) (Min–Max)
Dynamometer, right (kg) 26.14 (20.1–32.4) 4.55–54.55
SPPB 9 (6–11) 1–12
6MWT (m) 640 (520–720) 320–1040
TUG (s) 7.70 (6.39–9.21) 3.50–13.68
STS5 (s) 14 (11.7–17) 8–30
STS10 (s) 29 (24–36.25) 16–60
STS30 (repetitions) 10.50 (8–12) 5–19
STS60 (repetitions) 20 (15–24.2) 9–40
The results according to gender are  presented in Table 5,
males had greater strength measured by dynamometer than
the females. In the  functional capacity tests, there was a  sig-
nificant difference between males and females in the SPPB,
6MWT and STS60, with males achieving better results in the
SPPB and 6MWT, and females in the STS60. Although the result
was not statistically significant, the females obtained better
results in the rest of the tests.
Table 6 shows the correlation of the SPPB test with muscle
strength and other tests; it can be seen that a  better result in
the SPPB meant a  better result in the rest of the tests, i.e. they
Table 3 – Relationship between age and SPPB.
No.◦ of patients Age  range SPPB p
Severe limitations Moderate limitations Mild limitations Minimal
limitations –  no
limitations
33 <65 0% 3.03% 15.15% 81.82% 0.000
30 65–74 3.33% 6.67% 43.33% 46.67%
44 75–84 11.36% 29.55% 36.36% 22.73%
11 ≥85 9.09% 63.64% 18.18% 9.09%
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Table 5 – Test results for functional capacity and muscle strength with dynamometer by gender.
Median (P25–P75) males  (Min–Max) Median (P25–P75) females (Min–Max) p
Dynamometer, right (kg) 29.55 (25–36.36) 6.82–54.55 15.91 (13.1–20.4) 4.55–31.82 0.000
SPPB 9.50 (7–11) 2–12 8 (5–10.2) 1–12 0.040
6MWT (m) 640 (522.5–720) 320–104 620 (480–710) 385–800 0.000
TUG (s) 7.72 (6.39–9.29) 3.50–13.68 7.60 (6.5–9.05) 5.53–13.25 0.771
STS5 (s) 14 (1.7–17.2) 8–30 13 (11.2–17) 9–27 0.720
STS10 (s) 30 (24–37) 16–60 27 (24–34.2) 18–54 0.585
STS30 (repetitions) 10 (8–12) 5–19 11 (9–12) 6–17 0.514
STS60 (repetitions) 19 (15–23.2) 10–40 21.5 (14.2–25) 9–32 0.000
Table 6 – Relationship between SPPB, functional capacity test and muscle strength with dynamometer.
SPPB 6MWT TUG STS 5 STS 10  STS 30 STS 60
Dynamometer, right Coefficient of correlation 0.529 0.414 −0.456 −0.326 −0.305  0.286 0.304
p 0.000 0.000 0.000 0.003 0.005 0.009 0.005
6MWT Coefficient of correlation 0.636 − −0.676 −0.674 −0.667  0.658 0.675
p 0.000 − 0.000 0.000 0.000 0.000 0.000
TUG Coefficient of correlation −0.802  −0.676 −  0.703 0.772 −0.764 −0.762
p 0.000 0.000 –  0.000 0.000 0.000 0.000
[1,0]STS5 Coefficient of correlation −0.805  −0.674 0.703 –  0.934 −0.919 −0.861
p 0.000 0.000 0.000 –  0.000 0.000 0.000
STS10 Coefficient of correlation −0.857  −0.667 0.772 0.934 –  −0.985 −0.895
p 0.000 0.000 0.000 0.000 –  0.000 0.000
STS30 Coefficient of correlation 0.850 0.658 −0.764 −0.919 −0.985  –  0.901
p 0.000 0.000 0.000 0.000 0.000 –  0.000
STS60 Coefficient of correlation 0.827 0.675 −0.762 −0.861 −0.895  0.901 –
p 0.000 0.000 0.000 0.000 0.000 0.000 –
showed more  strength, walked further, had less risk of falling
and had better scores for time taken and number of times they
could sit down  and stand up. This was also found comparing
with muscle strength, i.e. having more  strength meant better
functional capacity.
When differentiating by gender, we found no significant
difference for BMI, AMC, MIS, CKD-EPI and CRP, but there was
a significant difference with TSF (0.000, higher in females)
and prealbumin (0.029, higher in males). Table 7 shows that
patients with better body composition had better functional
capacity and muscle strength, but this was not the  case with
the anthropometric parameters, where there was no statisti-
cal significance.
Lastly, with biochemistry parameters and the MIS, we only
found statistical significance with muscle strength, SPPB and
the 6MWT.  Prealbumin appeared to be a  good marker of mus-
cle strength and functional capacity measured with SPPB,
while inflammation status (CRP) influenced functionality, and
a worse nutritional status meant less strength, more  limita-
tions and less endurance.
Discussion
Assessment of functional capacity should be included in the
diagnosis and monitoring of renal patients, as these patients
have an increased risk of functional impairment. Functional
capacity tests have a good correlation with body composition,
muscle strength and parameters of nutritional status.
The study was carried out with assessment of the func-
tional capacity of patients from the advanced CKD clinic at
Madrid’s Hospital Universitario de la Princesa which is  per-
formed as part of routine clinical practice. The usual tests for
assessing functionality (6MWT, TUG, STS) could not be  applied
to all patients since not all patients were able to perform
such tests. A  significant number were left unassessed thus,
we sought a  test that was  easy to execute, quick to complete
and which could be used in all patients. The SPPB was  a good
alternative, despite being a test used in geriatric population. It
allowed to assess a greater number of patients, from the very
oldest to much younger patients who, for  various reasons, had
a reduction in  their functional capacity in whom it was very
difficult to  assess using the other physical fitness tests.
The advantage of using this test is  that in addition to not
requiring complex material, or  taking a  long time to complete,
it is  possible to assess virtually all patients. Although in young
people it may  be insufficient, it can serve as a screening test
before moving on to another battery or more  intense tests.
With the  increase in life expectancy, patients became older. It
is  necessary to include tools used mainly in  geriatrics for the
assessment, diagnosis and monitoring of these patients.25 The
SPPB is  a  very useful test, as  a variation of at least one point in
the score will have clinical significance.26 It is therefore possi-
ble to  quickly assess and detect deterioration, maintenance or
improvement in the patient’s functional capacity, enabling the
health care personnel to  act rapidly if necessary, recommend-
ing physical activity to  improve or maintain functionality.
Although most of the studies are  performed in HD, it is
important to stress that assessment of functional capacity is
necessary in  the  initial stages of the disease. In addition to  the
fact that deterioration may  occur early, once the time comes
to initiate renal replacement therapy, it is  important to ensure
that the patient has the minimal amount of complications. In
2013, Baback Roshanravan et  al.27 published a  study in which
they analysed mortality rates based on functional capacity,
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Table 7 – Relationship between test and dynamometer readings and bioimpedance body composition parameters,
clinical biochemistry parameters and malnutrition-inflammation score (MIS).
Dynamometer, right SPPB 6MWT TUG STS5 STS10 STS30 STS60
%BCM Coefficient of  correlation 0.139 0.400 0.270 −0.434 −0.344  −0.374 0.380 0.380
p 0.133 0.000 0.015 0.000 0.002 0.001 0.000 0.000
PA Coefficient of  correlation 0.305 0.477 0.269 −0.365 −0.370  −0.370 0.362 0.369
p 0.001 0.000 0.015 0.001 0.001 0.001 0.001 0.001
%TBW Coefficient of  correlation 0.440 0.281 0.193 −0.264 −0.177 −0.162 0.153 0.189
p 0.000 0.002 0.085 0.016 0.111 0.146 0.171 0.090
%ICW Coefficient of  correlation 0.395 0.552 0.364 −0.528 −0.437  −0.443 0.438 0.462
p 0.000 0.000 0.001 0.000 0.000 0.000 0.000 0.000
%MM Coefficient of  correlation 0.408 0.552 0.412 −0.583 −0.443  −0.453 0.454 0.503
p 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
%FM Coefficient of  correlation −0.482 −0.390 −0.279 0.409 0.279 0.27 −0.263 −0.317
p 0.000 0.000 0.012 0.000 0.011 0.014 0.017 0.004
BCMI Coefficient of  correlation 0.419 0.440 0.324 −0.508 −0.350  −0.38 0.395 0.396
p 0.000 0.000 0.003 0.000 0.001 0.000 0.000 0.000
Prealbumin Coefficient of  correlation 0.339 0.369 ns ns ns ns  ns ns
p 0.000 0.000 ns ns ns ns  ns ns
CRP Coefficient of  correlation ns −0.243 −0.229 ns ns 0.235 −0.247 ns
p ns 0.009 0.041 ns ns 0.034 0.026 ns
MIS Coefficient of  correlation −0.278 −0.348 −0.231 ns ns ns  ns ns
p 0.002 0.000 0.038 ns ns ns  ns ns
using as tools the 6MWT, TUG and dynamometer tests. They
assessed patients who  were in stages 2–4, and reported that a
decrease of 0.1 m/s  in gait speed, a decrease in muscle strength
and  an increase of 1 s in  the result of the TUG test increased
the mortality at 3 years.
There is little evidence on functional capacity assessment
in patients with CKD prior to  renal replacement therapy.
Özlem et al.8 published a  study in 2017 pointing out the  need
to assess the functional capacity of renal patients from early
stages and they used the SPPB test (regardless of age). In that
study, in addition to using the SPPB, they also used the TUG
test. In line with our results, they found that, regardless of the
patients’ age, compared to the TUG test, the SPPB was a  better
assessment test.
Another point to consider is how often to perform the
functional assessment. In a  study conducted by Lucia Ortega
et al.17 in 2015 in  Valencia (Spain), haemodialysis patients
were assessed with a test battery consisting of SPPB, STS10,
STS60, and the TUG test (also including the heel-rise test), per-
forming an initial assessment and another at six months. They
concluded that with the results obtained, it was not possible to
assess the deterioration in six months, and that longer studies
were therefore necessary.
Recent publications on HD and PD28,29 highlight the need
for assessment of functional capacity and show that the mon-
itoring of a physical activity, improving body composition and
functionality, leads to an  increase in both quality of life and
life expectancy. There are even studies30 which show statisti-
cally significant associations between anxiety and depression
and worse results in the 6MWT  and STS tests.
Conclusion
More  studies are needed in patients with advanced CKD, since
most publications are focused on haemodialysis population.
Functional capacity assessments should be performed as  part
of routine clinical practice in patients from advanced CKD
clinics, choosing the test that best suits the characteristics of
the patients.
In the absence of a consensus on the  best method to deter-
mine the functional capacity of renal patients, and with the
intention to  assess all patients, we propose the SPPB test as
a  screening method and, depending on the results, using the
6MWT, TUG test and STS tests (any of the 4 variants described)
to perform a  complete study if  necessary.
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